menu
    • menu

    Company profile for Cellectar

    NEW Drugs in Dev: 10
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer. Our core objective is to leverage our proprietary phospholipid drug conjugates™ (PDCs™) delivery platform to develop PDCs that specifically target cancer cells to deliver improved efficacy and better safety as a result of fewer off-target effects. The PDC™ platform possesses ...
    We are a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer. Our core objective is to leverage our proprietary phospholipid drug conjugates™ (PDCs™) delivery platform to develop PDCs that specifically target cancer cells to deliver improved efficacy and better safety as a result of fewer off-target effects. The PDC™ platform possesses the potential for the discovery and development of the next generation of cancer-targeting treatments and we plan to develop PDCs independently and through research and development collaborations.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CellectarUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    100 Campus Drive, Suite 207 Florham Park, NJ 07932
    Telephone
    Telephone
    608-441-8120
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cellectar.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cellectar Biosciences To Present Subset Of CLOVER Wam Trial Data
    Cellectar Biosciences To Present Subset Of CLOVER Wam Trial Data

    21 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7198560

    FIRSTWORD PHARMA
    21 Apr 2026
    Share Share
    Cellectar Initiates CLR 125 Trial For (TNBC) In Phase 1B
    Cellectar Initiates CLR 125 Trial For (TNBC) In Phase 1B

    14 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/14/3273404/29076/en/Cellectar-Enrolls-First-Patient-in-CLR-125-Auger-Emitting-Radioconjugate-Phase-1b-Clinical-Trial-Targeting-Refractory-Triple-Negative-Breast-Cancer-TNBC.html

    GLOBENEWSWIRE
    14 Apr 2026
    Share Share
    Cellectar Bio Reports 2025 Financials And Corporate Updates
    Cellectar Bio Reports 2025 Financials And Corporate Updates

    04 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/04/3249235/29076/en/Cellectar-Biosciences-Reports-Financial-Results-for-Year-Ended-2025-and-Provides-Corporate-Updates.html

    GLOBENEWSWIRE
    04 Mar 2026
    Share Share
    Cellectar Biosciences To Present Full-Year Financial Results
    Cellectar Biosciences To Present Full-Year Financial Results

    25 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/25/3244575/29076/en/Cellectar-Biosciences-to-Report-Full-Year-Financial-Results-and-Host-a-Conference-Call-on-Wednesday-March-4-2026.html

    GLOBENEWSWIRE
    25 Feb 2026
    Share Share
    Cellectar Biosciences Expands Global Intellectual Property Estate
    Cellectar Biosciences Expands Global Intellectual Property Estate

    17 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/17/3239238/29076/en/Cellectar-Biosciences-Expands-Global-Intellectual-Property-Estate.html

    GLOBENEWSWIRE
    17 Feb 2026
    Share Share
    Cellectar Bio Showcases 2026 Strategy At JP Morgan Conference
    Cellectar Bio Showcases 2026 Strategy At JP Morgan Conference

    09 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/09/3216069/29076/en/Cellectar-Biosciences-to-Highlight-Strategic-Initiatives-for-2026-at-Upcoming-Biotech-Showcase-during-44th-Annual-JP-Morgan-Healthcare-Conference.html

    GLOBENEWSWIRE
    09 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search